PTS, 6-pyruvoyltetrahydropterin synthase, 5805

N. diseases: 89; N. variants: 40
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1861172
Disease: Venous Thromboembolism
Venous Thromboembolism
0.010 Biomarker phenotype BEFREE Conclusion Surgical or interventional treatment is not advised except in exceptional cirumstances, due to variable prognosis of PTS in paediatric populations with rising incidence of paediatric venous thromboembolism, it follows that the prevalence of post-thrombotic syndrome in children may also increase. 28121229 2018
CUI: C0040822
Disease: Tremor
Tremor
0.100 Biomarker phenotype HPO
CUI: C0268464
Disease: Transient hyperphenylalaninemia
Transient hyperphenylalaninemia
0.010 GeneticVariation disease BEFREE The PTPS-deficient patient with the homozygous K129E allele had transient hyperphenylalaninemia, did not depend on BH4 replacement therapy, and showed normal PTPS immunoreactivity, but no enzyme activity in primary fibroblasts and red blood cells. 9222757 1997
CUI: C0238472
Disease: TOXOPLASMOSIS, CHRONIC
TOXOPLASMOSIS, CHRONIC
0.010 GeneticVariation disease BEFREE Notably, the PTS mutant can prevent acute as well as yet-incurable chronic toxoplasmosis in a mouse model, which endorses its potential clinical utility as a metabolically attenuated vaccine. 26565995 2015
CUI: C0037763
Disease: Spasm
Spasm
0.010 GeneticVariation phenotype BEFREE Paroxysmal tonic spasms [PTS] are common in patients with neuromyelitis optica spectrum disorder (NMOSD).1 2 In patients with demyelinating disease, PTS can significantly reduce the quality of life, limit activities of daily living and the rehabilitative process following an acute relapse 3. 28427706 2017
CUI: C2830004
Disease: Somnolence
Somnolence
0.100 Biomarker phenotype HPO
CUI: C0302511
Disease: Small for gestational age fetus
Small for gestational age fetus
0.100 Biomarker phenotype HPO
Small for gestational age (disorder)
0.100 Biomarker phenotype HPO
CUI: C0037036
Disease: Sialorrhea
Sialorrhea
0.100 Biomarker disease HPO
CUI: C0036572
Disease: Seizures
Seizures
0.100 Biomarker phenotype HPO
CUI: C0035021
Disease: Relapsing Fever
Relapsing Fever
0.100 Biomarker disease HPO
CUI: C3714772
Disease: Recurrent fevers
Recurrent fevers
0.100 Biomarker phenotype HPO
CUI: C0033377
Disease: Ptosis
Ptosis
0.100 Biomarker disease HPO
Progressive neurologic deterioration
0.100 Biomarker phenotype HPO
CUI: C0020501
Disease: Primary Hyperoxaluria
Primary Hyperoxaluria
0.010 Biomarker disease BEFREE Molecular recognition of PTS-1 cargo proteins by Pex5p: implications for protein mistargeting in primary hyperoxaluria. 25689234 2015
CUI: C0038436
Disease: Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
0.010 Biomarker disease BEFREE Findings also add to the ongoing discussions about the suitability of SAD as a PTSD-relevant trauma type and about the importance of trauma-related amnesia as a PTSD symptom. 30055470 2018
CUI: C1837142
Disease: Poor suck
Poor suck
0.100 Biomarker phenotype HPO
CUI: C1836038
Disease: Poor head control
Poor head control
0.100 Biomarker phenotype HPO
CUI: C0031485
Disease: Phenylketonurias
Phenylketonurias
0.030 Biomarker group BEFREE The transition regions contained other disease-related genes including APP associated with familial Alzheimer's disease (AD1), SOD1 associated with familial amyotrophic lateral sclerosis (ALS1) and PTS associated with phenylketonuria. 11772995 2002
CUI: C0031485
Disease: Phenylketonurias
Phenylketonurias
0.030 Biomarker group BEFREE To develop a rapid method for the diagnosis of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficiency, we designed a multiplex, PCR-based primer panel to amplify all the exons and flanking regions (50 bp average) of six PKU-associated genes (PAH, PTS, GCH1, QDPR, PCBD1 and GFRP). 24705691 2014
CUI: C0031485
Disease: Phenylketonurias
Phenylketonurias
0.030 Biomarker group BEFREE While such amino acidemias as branched-chain amino acidemia (MSUD) in classic and intermediate forms (44%) and hyperphenylalaninemia (PKU) due to 6-pyruvoyltetrahydropterin synthase deficiency (6PTSD) (19%) were common, classic PKU was rare (16%). 1588014 1992
CUI: C0268465
Disease: Phenylketonuria II
Phenylketonuria II
0.010 Biomarker disease BEFREE Further 11 patients were studied after receiving serotoninergic treatment (serotonin precursors, monoamine oxidase inhibitors, selective serotonin re-uptake inhibitors): 5 with aromatic L-amino acid decarboxylase deficiency; 1 with sepiapterin reductase deficiency; 3 with dihydropteridine reductase deficiency; and 2 with 6-pyruvoyltetrahydropterin synthase deficiency. 29116116 2017
CUI: C0016169
Disease: pathologic fistula
pathologic fistula
0.010 Biomarker phenotype BEFREE The initial ultrasound screening suggested PTS in all 24 cases, with arterialized waveform in veins in 24 cases and high-velocity turbulent flow within the fistulas in 16 cases. 30724058 2019
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders
0.100 Biomarker group HPO
CUI: C0030232
Disease: Pallor
Pallor
0.100 Biomarker phenotype HPO